Carmen B. Volkart - 31 Mar 2026 Form 4 Insider Report for Modular Medical, Inc. (MODD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Apr 2026, 17:00:20 UTC
Prior SEC filing
05 Jan 2026
Next SEC filing
08 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James Sullivan, Attorney in Fact for Carmen Volkart

Key filing fact

Carmen B. Volkart filed Form 4 for Modular Medical, Inc. (MODD) on 08 Apr 2026.

Key facts

  • This page summarizes Carmen B. Volkart's Form 4 filing for Modular Medical, Inc. (MODD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Apr 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 05 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001282953 Primary reporting owner

Volkart Carmen B

Relationship
Director
Address
C/O MODULAR MEDICAL, INC., 10740 THORNMINT ROAD, SAN DIEGO
Signature
/s/ James Sullivan, Attorney in Fact for Carmen Volkart
Signature date
08 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MODD transaction

Common Stock

Award

Transaction value
Shares
+103
Change %
+15%
Price
Shares after
806
Date
31 Mar 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Footnote F2

Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .